Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jason Goldberg
BARC

Jason Goldberg

Barclays
Wall Street Analyst
★★★☆☆
#1091
on 13Foresight · ranked by our own returns
49%
Success Rate
+2.5%
Average Return
89 of 181 calls profitable · +1.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 49% of Jason Goldberg's ratings turned a profit when each position was held for 1 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

159 Buy 103 Hold 46 Sell
Jason's Stock Coverage 34 ratings · 2026-11-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
NTRS
Northern
 Oct 30, 2026 HOLD Hold
-3.6% avg upside
23 analysts
$194.00
14.78% Upside
 +1.3% ·
STT
State Street
 Oct 29, 2026 HOLD Strong Buy
-1.5% avg upside
26 analysts
$200.00
17.80% Upside
 -4.9% ·
HBAN
Huntington Bancshares
 Oct 29, 2026 HOLD Strong Buy
+15.7% avg upside
30 analysts
$20.00
26.68% Upside
 +0.6% ·
FCNCA
First Citizens BancShares
 Oct 29, 2026 HOLD Buy
-1.1% avg upside
19 analysts
$2650.00
12.69% Upside
 -4.6% ·
TFC
Truist Financial
 Oct 29, 2026 SELL Buy
+11.0% avg upside
36 analysts
$56.00
14.72% Upside
 -3.3% ·
CFG
Citizens Financial
 Oct 29, 2026 BUY Strong Buy
+12.8% avg upside
27 analysts
$81.00
27.02% Upside
 -2.9% ·
WFC
Wells Fargo
 Oct 29, 2026 BUY Strong Buy
+0.6% avg upside
40 analysts
$108.00
29.57% Upside
 -1.0% ·
FITB
Fifth Third Bancorp
 Oct 20, 2026 BUY Strong Buy
+0.7% avg upside
33 analysts
$67.00
24.29% Upside
 +2.0% ·
ALLY
Ally Financial
 Oct 20, 2026 HOLD Strong Buy
+17.7% avg upside
29 analysts
$48.00
25.67% Upside
 +2.5% ·
ZION
Zions Bancorporation National Association
 Oct 20, 2026 SELL Hold
-0.4% avg upside
37 analysts
$72.00
10.10% Upside
 -2.8% ·
KEY
KeyCorp
 Oct 20, 2026 HOLD Strong Buy
+12.0% avg upside
31 analysts
$24.00
13.65% Upside
 +0.7% ·
MTB
M&T Bank
 Oct 19, 2026 HOLD Buy
+1.2% avg upside
31 analysts
$267.00
20.96% Upside
 +2.8% ·
RF
Regions Financial
 Oct 19, 2026 SELL Buy
+2.4% avg upside
34 analysts
$30.00
4.97% Upside
 -6.3% ·
USB
US Bancorp
 Oct 15, 2026 BUY Strong Buy
+7.1% avg upside
35 analysts
$75.00
26.12% Upside
 +4.1% ·
BNY
Bank of New York Mellon
 Oct 15, 2026 BUY Buy
-8.7% avg upside
28 analysts
$178.00
21.09% Upside
 +8.0% ·
PNC
PNC Financial
 Oct 15, 2026 BUY Buy
+10.4% avg upside
30 analysts
$284.00
24.65% Upside
 +6.6% ·
GS
Goldman Sachs Group
 Oct 14, 2026 BUY Buy
-4.9% avg upside
34 analysts
$1245.00
39.27% Upside
 -1.5% ·
BAC
Bank of America
 Oct 14, 2026 BUY Strong Buy
+2.6% avg upside
46 analysts
$68.00
36.00% Upside
 -3.2% ·
C
Citigroup
 Oct 14, 2026 BUY Strong Buy
-3.4% avg upside
37 analysts
$154.00
25.56% Upside
 +2.6% ·
JPM
JPMorgan Chase
 Oct 14, 2026 BUY Strong Buy
-19.0% avg upside
47 analysts
$425.00
26.17% Upside
 +0.6% ·
MS
Morgan Stanley
 Oct 14, 2026 BUY Buy
-4.0% avg upside
38 analysts
$262.00
42.15% Upside
 +0.3% ·
COF
Capital One Financial
 Sep 17, 2024 HOLD Strong Buy
+3.7% avg upside
44 analysts
$154.00
24.84% Downside
 +57.4% ·
FRCB
First Republic Bank
 Apr 24, 2023 HOLD Buy
+47593650.0% avg upside
22 analysts
$15.00
7499899.97% Upside
 · ·
RELY
Remitly Global
 Apr 14, 2023 BUY Strong Buy
+16.9% avg upside
14 analysts
$20.00
17.21% Downside
 +10.7% ·
CYTK
Cytokinetics
 Apr 03, 2023 BUY Strong Buy
+43.4% avg upside
36 analysts
$58.00
7.82% Downside
 +88.1% ·
AMRX
Amneal Pharmaceuticals
 Mar 02, 2023 BUY Strong Buy
-10.1% avg upside
19 analysts
$7.00
67.52% Downside
 +174.9% ·
ELAN
Elanco Animal Health
 Feb 17, 2023 HOLD Strong Buy
+35.1% avg upside
20 analysts
$18.00
22.00% Downside
 +23.8% ·
IDXX
Idexx Laboratories
 Jan 16, 2023 BUY Buy
+30.3% avg upside
19 analysts
$582.00
5.49% Upside
 +8.3% ·
AMAL
Amalgamated Bank
 Jan 28, 2022 BUY Buy
-30.1% avg upside
9 analysts
$22.00
55.99% Downside
 +41.0% ·
SICP
Silvergate Capital
 May 18, 2021 HOLD Hold
+11584.5% avg upside
12 analysts
$135.00
19470.90% Upside
 · ·
AUB
Atlantic Union Bankshares
 Apr 13, 2021 HOLD Strong Buy
+11.1% avg upside
15 analysts
$43.00
9.54% Upside
 -2.0% ·
EWBC
East West Bancorp
 Oct 09, 2015 BUY Strong Buy
-7.3% avg upside
26 analysts
$50.00
61.85% Downside
 +3.1% ·
TCBI
Texas Capital Bancshares
 Apr 26, 2012 HOLD Buy
-13.8% avg upside
23 analysts
$40.00
60.97% Downside
 +11.1% ·
FHN
First Horizon
 Jul 09, 2010 HOLD Buy
-0.2% avg upside
33 analysts
$15.00
35.58% Downside
 -21.7% ·
🔒 29 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jason Goldberg — Frequently Asked Questions
How accurate are Jason Goldberg's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Jason's ratings were profitable over a one-year hold, with an average return of +2.6% per rating, or +0.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Jason ranked on 13Foresight?
Jason Goldberg is currently ranked #1091 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jason cover?
Jason most recently has ratings on NTRS, STT, HBAN, FCNCA, TFC, CFG, WFC, FITB, ALLY, ZION, KEY, MTB and 22 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.